A study clarified how B cells and T helper 17 (TH17) cells contribute to experimental autoimmune encephalomyelitis, the commonly used mouse model for multiple sclerosis. The work addresses a debate about the model’s relevance and stakes out a more defined immunologic mechanism. By strengthening mechanistic validation around the cellular players, the research can influence how investigators interpret preclinical results in MS and decide which immunologic pathways to test therapeutically. The focus on B-cell and TH17 involvement adds specificity to model selection and target prioritization.